Skip to main content

BioPlus Acquisition Corp. (BIOS)

BioPlus Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Market Cap281.40M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out28.14M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Est. Earnings Daten/a

About BIOS

BioPlus Acquisition Corp. is a newly incorporated blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search on companies in the life sciences industry.

IndustryBlank Checks / SPAC
IPO DatePending
CEORoss Haghighat and J. Leighton Read, M.D.
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolBIOS
Full Company Profile


Life science-focused SPAC BioPlus Acquisition files for a $220 million IPO

BioPlus Acquisition, a blank check company targeting life sciences, filed on Tuesday with the SEC to raise up to $220 million in an initial public offering.

2 months ago - NASDAQ

BioPlus Acquisition IPO Registration Document (S-1)

BioPlus Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC